Literature DB >> 14687171

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population.

M Diaz-Rubio1, C Moreno-Elola-Olaso, E Rey, G R Locke, F Rodriguez-Artalejo.   

Abstract

AIM: To measure the prevalence of gastro-oesophageal reflux symptoms and to identify associated factors in a representative sample of the Spanish population.
METHODS: A telephone survey of 2500 subjects was performed using a validated questionnaire. The association of gastro-oesophageal reflux symptoms (defined as the presence of heartburn or acid regurgitation) and their clinical characteristics with potential risk factors was summarized using the odds ratios (OR) obtained by multiple logistic regression.
RESULTS: The response rate was 71.2%. The annual prevalence of gastro-oesophageal reflux symptoms was 31.6% [95% confidence interval (CI), 29.8-33.4] and the weekly prevalence was 9.8% (95% CI, 8.6-10.9). Gastro-oesophageal reflux symptoms were associated with excess weight (OR, 1.53; 95% CI, 1.23-1.92), obesity (OR, 1.74; 95% CI, 1.30-2.32), the psychosomatic symptom score (OR, 2.98; 95% CI, 2.41-3.67) and the presence of gastro-oesophageal reflux symptoms in a direct family member (OR, 1.61; 95% CI, 1.17-2.23). Gastro-oesophageal reflux symptoms of > or =10 years' duration were more frequent in obese subjects (OR, 1.92; 95% CI, 1.14-3.22) and those with a direct family member with gastro-oesophageal reflux symptoms (OR, 2.42; 95% CI, 1.44-4.06). Factors associated with gastro-oesophageal reflux symptoms of < or =1 year duration were a spouse with gastro-oesophageal reflux symptoms (OR, 2.33; 95% CI, 1.39-3.9) and the consumption of 1-5 aspirins/week (OR, 1.70; 95% CI, 1.01-2.86).
CONCLUSIONS: The prevalence of frequent gastro-oesophageal reflux symptoms in Spain is lower than that observed in other Western populations. The psychosomatic symptom score is the factor most strongly associated with gastro-oesophageal reflux symptoms. Long-term gastro-oesophageal reflux symptoms are associated with certain genetic factors (obesity, family history of gastro-oesophageal reflux symptoms), whereas short-term gastro-oesophageal reflux symptoms are associated with factors of probable environmental nature.

Entities:  

Mesh:

Year:  2004        PMID: 14687171     DOI: 10.1046/j.1365-2036.2003.01769.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  66 in total

1.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

2.  Helicobacter pylori and gastro-oesophageal reflux disease: important data were not presented.

Authors:  Ian L P Beales
Journal:  BMJ       Date:  2004-08-14

3.  Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area.

Authors:  Sushil Kumar; Saurabh Sharma; Tsering Norboo; Diskit Dolma; Angchuk Norboo; Tsering Stobdan; S Rohatgi; K Munot; Vineet Ahuja; Anoop Saraya
Journal:  Indian J Gastroenterol       Date:  2010-12-23

Review 4.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.

Authors:  T J Hayeck; C Y Kong; S J Spechler; G S Gazelle; C Hur
Journal:  Dis Esophagus       Date:  2010-03-26       Impact factor: 3.429

6.  Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.

Authors:  Hatsushi Yamagishi; Tomoyuki Koike; Shuichi Ohara; Toru Horii; Ryousuke Kikuchi; Shigeyuki Kobayashi; Yasuhiko Abe; Katsunori Iijima; Akira Imatani; Kaori Suzuki; Takanori Hishinuma; Junichi Goto; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

7.  GERD in Minority Populations.

Authors:  Frank K Friedenberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-06

8.  Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.

Authors:  Chin Hur; Tristan J Hayeck; Jennifer M Yeh; Ethan M Richards; Ethan B Richards; Stuart J Spechler; G Scott Gazelle; Chung Yin Kong
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

9.  The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Seyed Mehrbod Atshani; Sepideh Chagharvand; Fatemeh Souti
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

10.  The pathophysiological mechanisms of GERD in the obese patient.

Authors:  Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.